Status:
UNKNOWN
Celebrex Premedication in Teeth With Symptomatic Irreversible Pulpitis
Lead Sponsor:
Cairo University
Conditions:
Pulpitis
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
Assessing the efficacy of Celebrex premedication on pain during and after endodontic treatment in teeth with symptomatic irreversible pulpits
Detailed Description
Owing to the painful nature of endodotnic treatment in teeth with irreversible pulpits, administration of an analgesic and anti-inflammatory could help to lessen the perception of pain, hence decreasi...
Eligibility Criteria
Inclusion
- Medically free patients
- Patients able to understand Visual Analogue Scale and sign the informed conset
- Mandibular molar teeth with:
- Preoperative sharp pain
- Vital pulp tissue
- Normal peripaical radiographic appearance or slight widening of the lamina dura
Exclusion
- Patients allergic to NSAIDS
- Pregnant females
- Patients having significant systemic disorder
- Patients with psychological disturbances
- Patients with bruxism or clenching
- Teeth that have:
- Associated with swelling or fistulous tract
- Acute or chronic periapical abscess
- Greater than grade I mobility
- Periodontitis
- No possible restorability
- previous endodontic treatment
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT03339544
Start Date
December 1 2017
End Date
December 1 2019
Last Update
November 13 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.